15 CROSBY DRIVE, BEDFORD, MA
Reports Second Quarter 2026 Financial Results and Business Highlights
Amendment to 2021 Stock Incentive Plan Approved by Stockholders
Annual Report to Security Holders
Ocular Therapeutix to Present SOL-1 Trial Results at Macula Society Meeting
Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
CFO Departure - Donald Notman Takes Medical Leave; Jason Robins Appointed Int...
Other Events
Q2
Q1
FY 2024
Q3
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement